Literature DB >> 20850335

Percutaneous aortic valve replacement: valvuloplasty studies in vitro.

David Haberthür1, Georg Lutter, Marie Appel, Tim Attmann, René Schramm, Christoph Schmitz, René Bombien Quaden.   

Abstract

OBJECTIVE: Valvuloplasty of the aortic valve is currently used in selected patients for severe calcified aortic valve disease, but clinical effectiveness is low and complication rate remains high. In this study, the total particle load after valvuloplasty and the embolization risk of calcific debris into the coronary arteries was analyzed in an in vitro model.
METHODS: Three highly calcified human aortic leaflets have been sutured into a porcine annulus (N = 9). Both coronary arteries were separated and each was anastomized to a silicon line, which was drained off into a measuring beaker. Then valvuloplasty was performed (Thyshak II, 20 mm, 1.5 atm). After removal of the balloon, 100ml of sodium chloride solution irrigated the ascending aorta. After passing through the separated coronary arteries, the solution was filtered (filter size 0.45 μm), dried, and the total amount of particles was analyzed microscopically.
RESULTS: Nine experiments were analyzed. After valvuloplasty, all hearts showed a median of 18 particles larger than 1mm in the coronary arteries (range 0-307). The amount of particles smaller than 1mm was 6574 (median, range 2207-14200). In five cases, coronary arteries were completely occluded by bulky particles.
CONCLUSION: This study demonstrated a large amount of calcific particles after valvuloplasty with a consequently high risk for coronary embolic events in case of highly calcified aortic valves. In times of valvuloplasty rediscovering as part of transcatheter valve implantation, the risk of embolization should be taken into consideration and filtering techniques have to be developed.
Copyright © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20850335     DOI: 10.1016/j.ejcts.2010.07.045

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

1.  Predictors and Prognostic Implications of Myocardial Injury After Transcatheter Aortic Valve Replacement.

Authors:  Murat Can Guney; Telat Keles; Bilge Duran Karaduman; Huseyin Ayhan; Hakan Suygun; Muzaffer Kahyaoglu; Engin Bozkurt
Journal:  Tex Heart Inst J       Date:  2022-07-01

Review 2.  Myocardial injury associated with transcatheter aortic valve implantation (TAVI).

Authors:  Won-Keun Kim; Christoph Liebetrau; Arnaud van Linden; Johannes Blumenstein; Luise Gaede; Christian W Hamm; Thomas Walther; Helge Möllmann
Journal:  Clin Res Cardiol       Date:  2015-12-15       Impact factor: 5.460

3.  Post-Procedural Troponin Elevation and Clinical Outcomes Following Transcatheter Aortic Valve Implantation.

Authors:  Konstantinos C Koskinas; Stefan Stortecky; Anna Franzone; Crochan J O'Sullivan; Fabien Praz; Katazyrna Zuk; Lorenz Räber; Thomas Pilgrim; Aris Moschovitis; Georg M Fiedler; Peter Jüni; Dik Heg; Peter Wenaweser; Stephan Windecker
Journal:  J Am Heart Assoc       Date:  2016-02-19       Impact factor: 5.501

4.  Postprocedural Troponin Elevation and Mortality After Transcatheter Aortic Valve Implantation.

Authors:  Matthias Schindler; Florin Stöckli; Rico Brütsch; Philipp Jakob; Erik Holy; Jonathan Michel; Robert Manka; Paul Vogt; Christian Templin; Markus Kasel; Frank Ruschitzka; Barbara E Stähli
Journal:  J Am Heart Assoc       Date:  2021-10-29       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.